Atrial fibrillation (AF) Flashcards
Describe the pathogenesis of atrial fibrillation (AF)
Atrial fibrillation (AF) occurs when there is uncoordinated, rapid and irregular atrial contraction
Delay at the atrio-ventricular (AV) node means that only some of the atrial impulses are conducted to the ventricles, resulting in an irregular ventricular response
Name some of the aetiology of atrial fibrillation (AF)
Cardiac
- Hypertension – most common cause in developed countries
- Ischaemic heart disease – most common cause in developed countries
- Valvular disease e.g. Rheumatic heart disease, which typically affecting the mitral valve – most common cause in less developed countries
Non-cardiac
- Respiratory e.g. COPD, pneumonia, PE
- Endocrine e.g. Hyperthyroidism, DM
- Infective e.g. sepsis
- Drugs e.g. bronchodilators, thyroxine
- Lifestyle factors e.g. alcohol abuse, excessive caffeine, obesity
- Electrolyte disturbances e.g. hypokalaemia, hypomagnesaemia
What is the most common cause of atrial fibrillation (AF) is the developed world
Hypertension or Ischaemic heart disease
What is the most common cause of atrial fibrillation (AF) is the developing world
Rheumatic heart disease
Rheumatic heart disease typically affecting which heart valve?
Mitral valve
Name the two major complications of atrial fibrillation (AF)
Thrombus formation due to the poor coordination of the atrial contraction leads to stasis of blood within the atria. It can break off forming an embolus and block distal arteries causing:
- Cerebral embolus: acute stroke or TIA
- Limb embolus: acute ischaemic limb
- Abdominal embolus: acute mesenteric ischaemia, ischaemic hepatitis
- Lungs embolus: PE
Heart failure due to poor filling of the ventricles during diastole
Name some of the clinical features of atrial fibrillation (AF)
Symptoms:
- Asymptomatic - in most cases
- Palpitations
- Shortness of breath
- Syncope/Presyncope
- Symptoms of associated conditions e.g. stroke, sepsis or thyrotoxicosis
Signs
- Irregularly irregular pulse rate
- Absent ‘a’ wave on the jugular venous pressure
- Tachycardia
- Hypotension
- Features suggestive of the underlying cause e.g. hyperthyroidism, alcohol excess etc
- Features suggestive of complications resulting from the AF e.g. heart failure
What pulse rhythm is suggestive of atrial fibrillation (AF)
Irregularly irregular rhythm
Name the 3 hallmark ECG features of atrial fibrillation (AF)
Irregularly irregular rhythm
Absence of P waves
Irregular, fibrillating baseline

Management of AF comprises a combination of 3 components.
Name these components?
Rate control OR rhythm control
+/-
Anticoagulation to prevent thromboembolic events
Is rate or rhythm control the first line management for atrial fibrillation (AF)
Rate control is the most common type of management
Rate control is the first-line strategy unless:
- Reversible cause of the AF
- New-onset (onset <48 hours)
- AF is caused by heart failure
- They remain symptomatic despite being effectively rate controlled
What is the first line strategy in patients with new-onset AF (onset <48 hours):
a) Rate control
b) Rhythm control
b) Rhythm control
What is the first line strategy in patients with a reversible cause of the AF:
a) Rate control
b) Rhythm control
b) Rhythm control
What is the first line strategy in patients with AF secondary to heart failure:
a) Rate control
b) Rhythm control
b) Rhythm control
What is the first line strategy in patients with symptomatic AF despite effective rate control:
a) Rate control
b) Rhythm control
b) Rhythm control
Name the 4 incidences in which rhythm control would be the first-line strategy in the management of the AF?
- Reversible cause of the AF
- New-onset (onset <48 hours)
- AF is caused by heart failure
- They remain symptomatic despite being effectively rate controlled
Name the first line pharmaceutical agents for rate control of AF
Beta blocker e.g. Bisoprolol
When would beta blocker be contraindicated as the first line pharmaceutical agents for rate control of AF
Technically contraindicated in COPD and asthma
Cannot be used in hypotension because it will drop blood pressure
Name the second line pharmaceutical agents for rate control of AF (if they cant have beta blocker for whatever reason)
Calcium-channel blocker e.g. diltiazem
When would digoxin be a good option as the pharmaceutical agents for rate control AF and what needs to be put in place in order to safely use it
Digoxin could be considered only in sedentary people
Needs monitoring due to the risk of toxicity
What is the most commonly used beta-blocker in AF
Bisoprolol
When would calcium channel blocker be contraindicated as the first line pharmaceutical agents for rate control of AF
Contraindicated in heart failure
What is the most commonly used calcium channel blocker in the rate control of AF
Diltiazem or verapamil
Why should digoxin be avoided in younger patients
Increases cardiac mortality
Rhythm control aims to restore and/or maintain the heart in normal sinus rhythm.
Name the two methods rhythm control can be achieved
- Electrical cardioversion
- Pharmacological cardioversion e.g. amiodarone, flecainide, Sotalol
Describe what is involved in electrical cardioversion to rhythm control AF
Single event – shocks the heart back into sinus rhythm
What is the first line pharmacological cardioversion therapy for rhythm control of AF
Flecainide
Amiodarone
Describe the dosage of flecainide for pharmaceutical rhythm control of AF
Can be either given regularly or as a “pill in the pocket” when symptoms come on
Name an adverse effect of flecainide, a drug used in the pharmacological cardioversion of rhythm controlled AF
Can induce fatal arrhythmias in structurally abnormal hearts
Amiodarone is used for:
a) Rate control for AF
b) Rhythmg control of AF
Both
Rate and rhythm control
What is the second line pharmacological cardioversion therapy for rhythm control of AF
Sotalol – beta blocker with additional K channel blocker action
When is anticoagulation used in AF
In patients at high risk of developing a thrombus as a result of the AF or at high risk of bleeding
There risk is determined by various risk stratification tools e.g. CHA2DS2-VASc scoring and ORBIT Scoring
Name the risk stratification tool used to assess a patient’s annual risk of developing an embolic event in patients with AF
CHA2DS2-VASc scoring
Name the two risk stratification tools used to guide the need for anticoagulation therapy in patients with atrial fibrillation (AF)
CHA2DS2-VASc scoring
AND
ORBIT Scoring
Which of the risk stratification tools used to in the anticoagulation for AF assesses a patients risk of emboli formation:
a) CHA2DS2-VASc scoring
b) ORBIT Scoring
a) CHA2DS2-VASc scoring
Which of the risk stratification tools used to in the anticoagulation for AF assess patients risk of major bleeding events on anticoagulation.
a) CHA2DS2-VASc scoring
b) ORBIT Scoring
b) ORBIT Scoring
Name the risk stratification tool used to assess patients (with AF) risk of major bleeding events on anticoagulation
ORBIT Scoring
What CHA2DS2-VASc score should a patient start anticoagulation therapy?
Score ≥1: Start anticoagulation therapy in males
Score ≥ 2: Start anticoagulation therapy in females
What are the components of the CHA2DS2-VASc scoring

ORBIT Scoring is used as a risk stratification tool to assess patients with AF’s risk of major bleeding events on anticoagulation.
Describe the intrepreation of the ORBIT scoring?
Range: 0-7
- Score of 4-7: high risk
- Score of 3: Medium risk
- Score of 0-2: Low risk
An ORBIT score of what suggests a patient is a high risk of major bleeding events on anticoagulation
Score of 4-7
An ORBIT score of what suggests a patient is a medium risk of major bleeding events on anticoagulation
Score of 3
An ORBIT score of what suggests a patient is a low risk of major bleeding events on anticoagulation
Score 0-2
If a patient was started on a pharmaceutical agents for anticoagulation for their AF.
What is the first line pharmaceutical agent they would be offered?
Direct oral anticoagulants (DOACs)
If you wanted to start a patient of a pharmaceutical agent for anticoagulation in AF but direct oral anticoagulants (DOACs) were not suitable or not tolerated.
What is a suitable alternative?
Vitamin K antagonist (e.g. warfarin)
Name the Vitamin K-dependent clotting factors
Factor II (Prothrombin)
VII
IX
Protein C and S
Describe the mechanism of action of warfarin
Warfarin blocks vitamin K and thus prolongs the prothrombin time, which is the time it takes for blood to clot
Where is warfarin metabolised?
Warfarin is metabolised by the cytochrome P450 system in the liver
Thus INR will be affected by other drugs that influence the activity of the P450 system e.g. clarithromycin
What does INR stand for and what does it measure?
INR (international normalised ratio) measurement are required to assess how anticoagulated the patient is
What is the typical INR target range?
Normal INR target is usually 2 – 3
How is INR measured?
INR is a calculation of how the prothrombin time of the patient compares with the prothrombin time of a normal health adult. An INR of 1 indicates a normal prothrombin time. An INR of 2 indicates that the patient has a prothrombin time twice that of a normal healthy adult (it takes them twice as long to form a blood clot)
When there is uncontrolled or life-threatening bleeding, the anticoagulant effects of warfarin can be reversed using what agent?
Vitamin K
Give 2 examples of direct Xa inhibitors (a type of direct-acting oral anticoagulants (DOACs))
Apixaban
Rivaroxaban
Give an example of a Direct thrombin inhibitors (a type of direct-acting oral anticoagulants (DOACs))
Dabigatran
When there is uncontrolled or life-threatening bleeding, the anticoagulant effects of Direct Xa inhibitors can be reversed using what agent
Andexanet alfa
When there is uncontrolled or life-threatening bleeding, the anticoagulant effects of apixaban can be reversed using what agent
Andexanet alfa is the reversible agent of Direct Xa inhibitors e.g. apixaban
When there is uncontrolled or life-threatening bleeding, the anticoagulant effects of Direct thrombin inhibitors can be reversed using what agent
Idarucizumab (a monoclonal antibody against dabigatran)